[Journal logo]

Volume 66 
Part 1 
Page o154  
January 2010  

Received 16 November 2009
Accepted 11 December 2009
Online 16 December 2009

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.010 Å
R = 0.067
wR = 0.189
Data-to-parameter ratio = 7.5
Details
Open access

Ethyl (1R,4S,5R,9S,10R,13S)-5,9,13-trimethyl-14-methylene-14-oxotetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate

aThe College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, People's Republic of China
Correspondence e-mail: shihao@zjut.edu.cn

The title compound, C22H34O3, was synthesized from isosteviol. The asymmetric unit contains of two independent molecules with the same absolute configurations. In both the molecules, the three six-membered rings adopt chair conformations, the stereochemistry of the A/B and B/C ring junctions are trans, and the five-membered ring D adopts an envelope conformation.

Related literature

Since the title compound was prepared from isosteviol, the configuration can be deduced from the known chirality of the isosteviol, see: Rodrigues & Lechat (1988[Rodrigues, A. M. G. D. & Lechat, J. R. (1988). Acta Cryst. C44, 1963-1965.]), Xue et al. (1993[Xue, J. Y., Tang, S. X., Cao, Y. R., Wang, X. L., Wang, R. J., Wang, H. G. & Lu, X. J. (1993). Chem. Res. Chin. Univ. 9, 201-207.]). For the pharmacological activity of isosteviol, see: Liu et al. (2001[Liu, J. C., Kao, P. F., Hsieh, M. H., Chen, Y. J. & Chan, P. (2001). Acta Cardiol. Sin. 17, 133-140.]); Mizushina et al. (2005[Mizushina, Y., Akihis, T., Ukiya, M., Hamasaki, Y., Murakami-Nakai, C., Kuriyama, I., Takeuchi, T., Sugawara, F. & Yoshid, H. (2005). Life Sci. 77, 2127-2140.]); Wong et al. (2004[Wong, K. L., Chan, P., Yang, H. Y., Hsu, F. L., Liu, I. M., Cheng, Y. W. & Cheng, J. T. (2004). Life Sci. 74, 2379-2387.]); Zhang & Xu (2004[Zhang, S. J. & Xu, D. Y. (2004). Chin. J. Pharmacol. Toxicol. 18, 427-432.]). For ring conformations, see: Cremer & Pople (1975[Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.]).

[Scheme 1]

Experimental

Crystal data
  • C22H34O3

  • Mr = 346.49

  • Triclinic, P 1

  • a = 6.5365 (9) Å

  • b = 12.5639 (15) Å

  • c = 13.1212 (16) Å

  • [alpha] = 69.174 (1)°

  • [beta] = 87.518 (2)°

  • [gamma] = 79.018 (1)°

  • V = 988.4 (2) Å3

  • Z = 2

  • Mo K[alpha] radiation

  • [mu] = 0.08 mm-1

  • T = 293 K

  • 0.49 × 0.42 × 0.15 mm

Data collection
  • Bruker SMART CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 1999[Bruker (1999). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.964, Tmax = 0.989

  • 5226 measured reflections

  • 3451 independent reflections

  • 1824 reflections with I > 2[sigma](I)

  • Rint = 0.034

Refinement
  • R[F2 > 2[sigma](F2)] = 0.067

  • wR(F2) = 0.189

  • S = 0.90

  • 3451 reflections

  • 459 parameters

  • 3 restraints

  • H-atom parameters constrained

  • [Delta][rho]max = 0.26 e Å-3

  • [Delta][rho]min = -0.27 e Å-3

Table 1
Comparison of the puckering parameters (Å, °) for the six and five-membered rings in molecules 1 and 2

Molecule   1     2  
Puckering parameters Q [theta] [varphi] Q [theta] [varphi]
Ring A1, A2 0.536 (7) 180.0 (7) 273 (27) 0.545 (8) 177.2 (8) 251 (29)
Ring B1, B2 0.557 (7) 9.5 (7) 72 (4) 0.561 (7) 7.8 (7) 71 (5)
Ring C1, C2 0.633 (7) 164.8 (6) 120 (3) 0.646 (8) 163.2 (7) 131 (2)
Puckering parameters   q2 [varphi]2   q2 [varphi]2
Ring D1, D2   0.467 (8) 333.7 (10)   0.452 (8) 332.2 (11)
Ring A1 atoms C2-C7, A2 C24-C29, B1 C6-C11, B2 C28-C33, C1 C10-C14/C17, C2 C32-C36/C39, D1 C14-C16/C10/C17 and D2 C36-C38/C32/C39.

Data collection: SMART (Bruker, 1999[Bruker (1999). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 1999[Bruker (1999). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: SHELXL97 nd PLATON (Spek, 2009[Wong, K. L., Chan, P., Yang, H. Y., Hsu, F. L., Liu, I. M., Cheng, Y. W. & Cheng, J. T. (2004). Life Sci. 74, 2379-2387.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: DN2514 ).


Acknowledgements

This material is based upon work funded by the Zhejiang Provincial Natural Science Foundation of China under grant No. Y2090552 and the Open Foundation of Key Disciplines within the Zhejiang Provincial Key Disciplines.

References

Bruker (1999). SMART, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.  [CrossRef] [ChemPort] [ISI]
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Liu, J. C., Kao, P. F., Hsieh, M. H., Chen, Y. J. & Chan, P. (2001). Acta Cardiol. Sin. 17, 133-140.
Mizushina, Y., Akihis, T., Ukiya, M., Hamasaki, Y., Murakami-Nakai, C., Kuriyama, I., Takeuchi, T., Sugawara, F. & Yoshid, H. (2005). Life Sci. 77, 2127-2140.  [ISI] [CrossRef] [PubMed] [ChemPort]
Rodrigues, A. M. G. D. & Lechat, J. R. (1988). Acta Cryst. C44, 1963-1965.  [CrossRef] [details]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2009). Acta Cryst. D65, 148-155.  [ISI] [CrossRef] [details]
Wong, K. L., Chan, P., Yang, H. Y., Hsu, F. L., Liu, I. M., Cheng, Y. W. & Cheng, J. T. (2004). Life Sci. 74, 2379-2387.  [ISI] [CrossRef] [PubMed] [ChemPort]
Xue, J. Y., Tang, S. X., Cao, Y. R., Wang, X. L., Wang, R. J., Wang, H. G. & Lu, X. J. (1993). Chem. Res. Chin. Univ. 9, 201-207.  [ChemPort]
Zhang, S. J. & Xu, D. Y. (2004). Chin. J. Pharmacol. Toxicol. 18, 427-432.


Acta Cryst (2010). E66, o154  [ doi:10.1107/S1600536809053380 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.